LONDON July 26 – GSK raised its full-year profit and sales guidance on Wednesday after its second-quarter earnings beat expectations, helped by strong sales of its shingles vaccine Shingrix and HIV medicines.
.
July 26, 2023 - 12:23
By Pharos Investment Advisors Comments are Off
LONDON July 26 – GSK raised its full-year profit and sales guidance on Wednesday after its second-quarter earnings beat expectations, helped by strong sales of its shingles vaccine Shingrix and HIV medicines.
.
June 23, 2023 - 17:27
By Pharos Investment Advisors Comments are Off
U.S.-listed shares of GSK were rising in premarket trading Friday after the pharmaceutical company said it reached a first legal settlement over claims that heartburn medication Zantac can cause cancer.
Regulated by Hellenic Capital Market Commission
with Registration Number 5/700/10.12.2014
Copyright 2023©. All Rights Reserved